Evidence map›Paper›PMID 38622194›Full record

ArticleScientific reports2024

Protein feature engineering framework for AMPylation site prediction.

Hardik Prabhu, Hrushikesh Bhosale, Aamod Sane, Renu Dhadwal, Vigneshwar Ramakrishnan, Jayaraman Valadi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hardik PrabhuComputing and Data Sciences, FLAME University, Pune, 412115, India.
Hrushikesh BhosaleComputing and Data Sciences, FLAME University, Pune, 412115, India.
Aamod SaneComputing and Data Sciences, FLAME University, Pune, 412115, India.
Renu DhadwalComputing and Data Sciences, FLAME University, Pune, 412115, India.
Vigneshwar RamakrishnanBioinformatics Center, School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India.
Jayaraman ValadiComputing and Data Sciences, FLAME University, Pune, 412115, India. jayaraman.vk@flame.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AMPylation is a biologically significant yet understudied post-translational modification where an adenosine monophosphate (AMP) group is added to Tyrosine and Threonine residues primarily. While recent work has illuminated the prevalence and functional impacts of AMPylation, experimental identification of AMPylation sites remains challenging. Computational prediction techniques provide a faster alternative approach. The predictive performance of machine learning models is highly dependent on the features used to represent the raw amino acid sequences. In this work, we introduce a novel feature extraction pipeline to encode the key properties relevant to AMPylation site prediction. We utilize a recently published dataset of curated AMPylation sites to develop our feature generation framework. We demonstrate the utility of our extracted features by training various machine learning classifiers, on various numerical representations of the raw sequences extracted with the help of our framework. Tenfold cross-validation is used to evaluate the model's capability to distinguish between AMPylated and non-AMPylated sites. The top-performing set of features extracted achieved MCC score of 0.58, Accuracy of 0.8, AUC-ROC of 0.85 and F1 score of 0.73. Further, we elucidate the behaviour of the model on the set of features consisting of monogram and bigram counts for various representations using SHapley Additive exPlanations.

Indexed as

Protein Processing, Post-TranslationalTyrosineAdenosine MonophosphateAmino Acid SequenceThreonineAdenosine MonophosphateThreonineTyrosine

Identifiers

PMID38622194
PMCPMC11369087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.